Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 25.47% is 21% above its 5-year average of 21.10%, near the high end of its 5-year range (-142.47%–35.95%).
1.36% above its 12-month average of 25.13%.
Reported quarterly gross margin; no daily interpolation. Q1 FY2027 (2026-06-30): 27.40%.
GROSS MARGIN
25.47%
GROSS MARGIN AVG TTM
25.13%
GROSS MARGIN AVG 3Y
27.11%
GROSS MARGIN AVG 5Y
21.10%
GROSS MARGIN AVG 10Y
23.94%
GROSS MARGIN AVG 15Y
40.89%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+1.36%
CURRENT VS 3Y AVG
-6.06%
CURRENT VS 5Y AVG
+20.71%
CURRENT VS 10Y AVG
+6.40%
CURRENT VS 15Y AVG
-37.72%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
46.31%
median of 426 covered companies
CURRENT VS SECTOR MEDIAN
-45.01%
vs the sector median at left
Canopy Growth Corporation
Market Cap
$373.40M
Gross Margin
25.47%
TTM Avg
25.13%
3Y Avg
27.11%
5Y Avg
21.10%
Market Cap
$368.91M
Gross Margin
93.73%
TTM Avg
92.44%
3Y Avg
93.34%
5Y Avg
78.89%
Market Cap
$366.39M
Gross Margin
98.15%
TTM Avg
96.49%
3Y Avg
98.25%
5Y Avg
98.83%
Market Cap
$348.59M
Gross Margin
0.00%
TTM Avg
50.00%
3Y Avg
75.00%
5Y Avg
66.67%
Market Cap
$345.48M
Gross Margin
62.61%
TTM Avg
61.15%
3Y Avg
61.24%
5Y Avg
64.05%
Market Cap
$406.47M
Gross Margin
77.34%
TTM Avg
76.74%
3Y Avg
77.57%
5Y Avg
77.57%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canopy Growth Corporation (CGC) | $373.40M | 25.47% | 25.13% | 27.11% | 21.10% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $368.91M | 93.73% | 92.44% | 93.34% | 78.89% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $366.39M | 98.15% | 96.49% | 98.25% | 98.83% |
| Agenus Inc. (AGEN)vs › | $363.54M | 29.63% | -10.58% | -43.61% | -33.41% |
| Embecta Corp. (EMBC)vs › | $348.85M | 59.89% | 63.90% | 65.83% | 67.05% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $348.59M | 0.00% | 50.00% | 75.00% | 66.67% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $345.48M | 62.61% | 61.15% | 61.24% | 64.05% |
| Shoulder Innovations, Inc. (SI)vs › | $406.47M | 77.34% | 76.74% | 77.57% | 77.57% |
| Cabaletta Bio, Inc. (CABA)vs › | $339.15M | 0.00% | 0.00% | 0.00% | 0.00% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $408.21M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
25.5%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 27.40% |
| 2026-03-31 | 11.60% |
| 2025-12-31 | 28.80% |
| 2025-09-30 | 32.85% |
| 2025-06-30 | 25.01% |
| 2025-03-31 | 16.21% |
| 2024-12-31 | 32.23% |
| 2024-09-30 | 34.67% |
| 2024-06-30 | 34.78% |
| 2024-03-31 | 21.25% |
| 2023-12-31 | 35.95% |
| 2023-09-30 | 33.66% |
| 2023-06-30 | 18.05% |
| 2023-03-31 | -141.26% |
| 2022-12-31 | 6.16% |
| 2022-09-30 | -0.69% |
| 2022-06-30 | -5.27% |
| 2022-03-31 | -142.47% |
| 2021-12-31 | 7.16% |
| 2021-09-30 | -54.15% |
| 2021-06-30 | 20.00% |
| 2021-03-31 | 6.60% |
| 2020-12-31 | 16.12% |
| 2020-09-30 | 19.28% |
| 2020-06-30 | 5.88% |
| 2020-03-31 | -190.55% |
| 2019-12-31 | 30.87% |
| 2019-09-30 | 4.76% |
| 2019-06-30 | 20.21% |
| 2019-03-31 | 72.81% |
| 2018-12-31 | 19.12% |
| 2018-09-30 | -145.69% |
| 2018-06-30 | 162.00% |
| 2018-03-31 | 31.47% |
| 2017-12-31 | 76.18% |
| 2017-09-30 | 152.21% |
| 2017-06-30 | 114.55% |
| 2017-03-31 | 9.67% |
| 2016-12-31 | 173.74% |
| 2016-09-30 | 186.24% |
| 2016-06-30 | 49.33% |
| 2016-03-31 | 53.31% |
| 2015-12-31 | 79.17% |
| 2015-09-30 | 383.10% |
| 2015-06-30 | 239.43% |
| 2015-03-31 | -32.39% |
| 2014-12-31 | 35.96% |
| 2014-09-30 | 23.56% |
| 2014-06-30 | 58.17% |
| 2014-03-31 | 0.00% |
| 2014-01-31 | 0.00% |
| 2013-10-31 | 100.00% |
| 2013-07-31 | 100.00% |
| 2013-04-30 | 100.00% |
| 2013-01-31 | 100.00% |
| 2012-10-31 | 0.00% |
| 2012-07-31 | 0.00% |
| 2012-04-30 | 0.00% |
| 2012-01-31 | 100.00% |
| 2011-10-31 | 100.00% |
| 2011-07-31 | 100.00% |
| 2011-04-30 | 100.00% |
| 2011-01-31 | 100.00% |
| 2010-10-31 | 100.00% |
| 2010-07-31 | 100.00% |
| 2010-04-30 | 0.00% |
| 2010-01-31 | 0.00% |
